NEW YORK, April 4, 2017 /PRNewswire/ -- Report DetailsThe pharmaceutical contract manufacturing market is expected to grow at a CAGR of 6.4% in the first half of the forecast period and CAGR of 5.7% in the second half of the forecast period. The market is estimated at $88bn in 2021 and $124bn in 2027.Read the full report: http://www.reportlinker.com/p04810650/Pharmaceutical-Contract-Manufacturing-Market.htmlHow this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 235-page report you will receive 82 tables and 61 figures– all unavailable elsewhere.The 235-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand new report today you stay better informed and ready to act.Report Scope- Global Pharmaceutical Contract Manufacturing Market forecasts from 2017-2027Submarket forecasts at world level, from 2017-2027:- Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs) and other products- Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages and other dosage types- Other applications of outsourced production - other related servicesRevenue forecasts from 2017-2027, for 12 countries:- United States (US)- EU5: Germany, France, the UK, Italy and Spain- BRIC: Brazil, Russia, India and China- South Korea- Japan- Assessment of selected leading companies that hold major market shares in the pharmaceutical contract manufacturing industry- Qualitative Analysis from a CMO Perspective 2016-2027- Qualitative Analysis from a Client Perspective 2016-2027Visiongain's study is intended for anyone requiring commercial analyses for the Pharmaceutical Contract Manufacturing Market. You find data, trends and predictions.Buy our report today Pharmaceutical Contract Manufacturing Market 2017-2027: Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages.Read the full report: http://www.reportlinker.com/p04810650/Pharmaceutical-Contract-Manufacturing-Market.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com
__________________________Contact Clare: [email protected]
US: (339)-368-6001Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharmaceutical-contract-manufacturing-market-2017-2027-300434670.html
SOURCE Reportlinker
